We are delighted to announce that Lidings has updated The Pharma Legal Handbook: Russia - practical directory focused on the key aspects of legislative regulation of pharmaceutical industry in Russia.

Lidings takes high positions in the new rating of the leading legal advisors in Russia based on the analytical research held annually by the “Kommersant” newspaper. In 2024 the firm is ranked among the TOP leading legal advisors in Russia. 

On April 11, 2024, in Moscow, the annual Pravo.ru conference "Pharmaceuticals – 2024: Legal Issues" will take place. Lidings lawyers traditionally take an active part in the event’s program.

As a strategic partner of the conference, we have endeavored to make the program as comprehensive and useful as possible. Together with experts from the pharmaceutical industry and legal experts, we will discuss current issues in industry regulation, legislative changes, market access, government procurement, and distribution. We will also touch upon marketing and promotion issues, as well as discuss strategies for protecting intellectual property.

In March 2024 Lidings partner Stepan Guzey visited the UAE (Dubai), Oman (Muscat), the Kingdom of Saudi Arabia (Riyadh) and Bahrain (Manama) during his regular business trip to the Middle East.

During the two-week visit Stepan held more than 25 business meetings with representatives of leading local law firms and government agencies to establish and strengthen partnerships, as well as discussed current and future projects with clients to whom Lidings provides comprehensive legal support for both outward and inward investment projects in the Middle East region.

On 16 February 2024, a draft law No. 554499-8 “On Amending Article 10 of the Federal Law ‘On the Procedure for Foreign Investments in Business Entities of Strategic Importance for Ensuring National Defense and State Security’” (the “Draft Law”) was submitted to the State Duma of the Russian Federation. The Draft Law provides for assessment of the economic and social consequences of foreign investments in Russian business entities of strategic importance.

Resolution of the Government of the Russian Federation No. 295 dated 6 March 2022, which establishes the general procedure for issuing permissions for deals prohibited by presidential decrees, was amended by Resolution of the Government of the Russian Federation No. 40 dated 22 January 2024 (“Resolution No. 40”).

The amendments concern the list of documents and information that should be submitted to the subcommission of the Government Commission for Control over Foreign Investments in the Russian Federation (“Commission”) to obtain permission for deals with securities (shares, contributions) of Russian legal entities.

On 24 January 2024, the State Duma Committee for the Financial Market proposed to adopt for consideration Draft law № 531412-8 “On Amending Article 45-6 of the Federal Law "On the Central Bank of the Russian Federation (Bank of Russia)"” (hereinafter - the “Draft law”).

The authors of the Draft law were a group of senators and deputies led by Anatoly Aksakov, Chairman of the State Duma Committee on the Financial Market.

The Draft law proposes to authorize the Bank of Russia to limit the share of loans secured by a pledge of buildings, structures, land plots, construction in progress, residential and non-residential premises and parts of buildings or structures (parking spaces) intended to accommodate vehicles.

On 16 January 2024 the State Duma adopted in the first reading the draft law No. 412669-8 “On Amendments to Chapter 4 of the Federal Law “On the Basics of State Regulation of Trade Activities in the Russian Federation” (“Draft law”). The Draft law proposes to introduce a number of changes to the regulation of companies engaged in consumer market research, provided they receive revenue in the amount of more than 30 million rubles per year.